시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 비교리스트
세계의 지속적 신대체요법 시장 보고서(2025년)
Continuous Renal Replacement Therapy Global Market Report 2025
상품코드 : 1703222
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 200 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,339,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,163,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 11,987,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

지속적 신장대체요법 시장 규모는 향후 수년간 빠르게 성장할 것으로 예상되며, 2029년까지 연평균 성장률(CAGR) 10.9%로 26억 4,000만 달러에 달할 것으로 예상됩니다. 예측 기간의 성장은 만성 신장질환 증가, 당뇨병 유병률 증가, 중환자실 입원 수 증가, 의료 인프라 투자 증가, 소아 의료에 대한 적용 확대 등에 기인합니다. 예측 기간의 주요 동향으로는 급속한 발전, 신기술 발표, 기술 발전, 제품 혁신, 기술적으로 진보된 CRRT 제품 등이 있습니다.

만성콩팥병(CKD)의 유병률 증가는 향후 지속적 신대체요법(CRRT) 시장의 성장을 촉진할 것으로 예상되며, 만성콩팥병은 신장 기능이 점차 저하되어 혈액에서 노폐물을 걸러내는 장기의 능력이 손상되는 장기적인 질환입니다. 이러한 CKD 사례 증가는 생활습관의 변화, 고령화, 당뇨병 및 고혈압 유병률 증가 등의 요인에 기인합니다. 지속적 신대체요법은 일반적으로 CKD의 급성 악화 및 합병증 관리에 사용되며, 체액 균형을 조절하고 대사성 노폐물을 지속적으로 제거하는 데 도움이 됩니다. 예를 들어 2024년 5월 미국 질병예방통제센터(CDC)는 미국 성인 3,550만 명 이상(약 7명 중 1명)이 CKD를 앓고 있다고 보고했습니다. 놀랍게도 이들 중 90%에 가까운 사람들이 자신의 병을 모르고 있으며, 이는 미국내 조기 발견과 인식 제고에 큰 격차가 있음을 보여줍니다.

지속적 신대체요법(CRRT) 시장의 주요 기업은 투석 환자를 위한 첨단 신장 치료 솔루션 개발에 주력하고 있으며, 치료 효과 개선, 환자 예후 개선, 기존 투석법과 관련된 합병증 감소를 목표로 하고 있습니다. 기존 투석과 달리, 이 치료법은 연속적으로(보통 24시간) 시행되며, 신체 친화적이기 때문에 특히 급성 신장 손상이나 중증 질환을 앓고 있는 환자들에게 적합합니다. 예를 들어 2023년 1월, 미국에 위치한 응급 및 수술 서비스를 제공하는 의료 시설인 페코닉 베이 메디컬 센터(PBMC)는 투석 환자를 위한 새로운 신장 치료 옵션을 도입했습니다. 이 치료법은 건강 상태로 인해 표준 투석을 견딜 수 없는 환자들에게 보다 편안한 투석을 제공하도록 설계되었으며, CRRT는 기존 투석보다 점진적으로 시행되므로 중증 환자의 스트레스를 줄이는 데 도움이 됩니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 신형 코로나바이러스 및 경기회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 대기업과 혁신적 기업

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 합병과 인수

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

KSA
영문 목차

영문목차

Continuous renal replacement therapy (CRRT) is a form of dialysis that provides gradual, ongoing blood filtration to help regulate levels of fluids, electrolytes, and waste products in critically ill patients with acute kidney injury (AKI) who are hemodynamically unstable. It plays a crucial role in managing fluid overload in critically ill patients, particularly those who cannot tolerate rapid fluid removal through intermittent hemodialysis due to cardiovascular instability.

The primary products in the continuous renal replacement therapy market are systems and consumables. A continuous renal replacement therapy (CRRT) system is a specialized medical device utilized in treating critically ill patients with AKI or other renal conditions. It offers various renal and non-renal therapies using different modalities such as slow continuous ultrafiltration (SCUF), continuous venovenous hemofiltration (CVVH), continuous venovenous hemodialysis (CVVHD), and continuous venovenous hemodiafiltration (CVVHDF). These therapies are administered to adults, pediatrics, and neonates in various settings including hospitals, ambulatory care centers, and homecare setups.

The continuous renal replacement therapy market research report is one of a series of new reports from The Business Research Company that provides continuous renal replacement therapy market statistics, including continuous renal replacement therapy industry global market size, regional shares, competitors with a continuous renal replacement therapy market share, detailed continuous renal replacement therapy market segments, market trends and opportunities, and any further data you may need to thrive in the continuous renal replacement therapy industry. This continuous renal replacement therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The continuous renal replacement therapy market size has grown rapidly in recent years. It will grow from $1.57 billion in 2024 to $1.74 billion in 2025 at a compound annual growth rate (CAGR) of 11.3%. The growth in the historic period can be attributed to increased demand for advanced CRRT devices, an increase in the prevalence of incidence of acute kidney injury, a rise in the number of medical applications, a high prevalence of co-morbidities, and continuous research and development.

The continuous renal replacement therapy market size is expected to see rapid growth in the next few years. It will grow to $2.64 billion in 2029 at a compound annual growth rate (CAGR) of 10.9%. The growth in the forecast period can be attributed to increasing incidences of chronic kidney diseases, rising prevalence of diabetes, a growing number of ICU admissions, rising investments in healthcare infrastructure, and expanding applications in pediatric care. Major trends in the forecast period include rapid advancements, launches of new technologies, technological advancements, product innovation, and technologically advanced CRRT products.

The growing prevalence of chronic kidney disease (CKD) is expected to drive the expansion of the continuous renal replacement therapy (CRRT) market in the future. CKD is a long-term condition in which kidney function gradually declines, impairing the organ's ability to filter waste from the blood. This increase in CKD cases is largely attributed to factors such as lifestyle changes, an aging population, and higher rates of diabetes and hypertension. Continuous renal replacement therapy is commonly used to manage acute exacerbations or complications of CKD, helping to regulate fluid balance and remove metabolic waste continuously. For example, in May 2024, the Centers for Disease Control and Prevention (CDC) reported that more than 35.5 million adults in the United States-about 1 in 7-are affected by CKD. Alarmingly, nearly 90% of these individuals are unaware of their condition, highlighting the significant gap in early detection and awareness efforts in the U.S.

Leading companies in the continuous renal replacement therapy (CRRT) market are concentrating on developing advanced renal therapy solutions for dialysis patients, aiming to improve treatment effectiveness, enhance patient outcomes, and reduce complications linked to conventional dialysis methods. Unlike traditional dialysis, this therapy runs continuously-usually over a 24-hour period-and is gentler on the body, making it particularly suitable for patients with acute kidney injuries or severe medical conditions. For example, in January 2023, Peconic Bay Medical Center (PBMC), a U.S.-based healthcare facility offering emergency and surgical services, introduced a new renal therapy option for dialysis patients. This therapy is designed to offer greater comfort to patients who may not tolerate standard dialysis due to their health conditions. CRRT is administered more gradually than traditional dialysis, which helps reduce stress on critically ill patients.

In August 2024, Baxter International Inc., a U.S.-based healthcare company known for producing medical products, acquired The Carlyle Group Inc. for $3.8 billion. This acquisition allows Carlyle Group to strengthen its portfolio in renal care, positioning itself to capitalize on the increasing demand for innovative dialysis products and services for patients with chronic kidney disease. The Carlyle Group Inc. is a U.S.-based investment firm with a focus on continuous renal replacement therapy.

Major companies operating in the continuous renal replacement therapy market are Medtronic Plc, Fresenius Medical Care AG & Co. KGaA, Asahi Kasei Corporation, Toray Industries Inc., Baxter International Inc., B. Braun Melsungen AG, Terumo Corporation, Nipro Corporation, NxStage Medical Inc., Hillrom Holdings Inc., Gambro AB, JMS Co. Ltd., Quanta Dialysis Technologies Ltd., Bellco S.r.l., Ningbo Tianyi Medical Devices Co. Ltd., Cytosorbents Corporation, Kawasumi Laboratories Inc., Medica S.p.A., Infomed SA, Medites Pharma Spol. S.R.O, Nikkiso Co. Ltd., Anjue Medical Equipment Co. Ltd., Medcomp Systems Ltd.

North America was the largest region in the continuous renal replacement therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the continuous renal replacement therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the continuous renal replacement therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The continuous renal replacement therapy (CRRT) market consists of revenues earned by entities by providing services such as acute hemodialysis, aquapheresis, and fluid management. The market value includes the value of related goods sold by the service provider or included within the service offering. The continuous renal replacement therapy market also includes sales of dialysis catheters, dialysates, hemostatic agents, and airway clearance systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Continuous Renal Replacement Therapy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on continuous renal replacement therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for continuous renal replacement therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The continuous renal replacement therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Continuous Renal Replacement Therapy Market Characteristics

3. Continuous Renal Replacement Therapy Market Trends And Strategies

4. Continuous Renal Replacement Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Continuous Renal Replacement Therapy Growth Analysis And Strategic Analysis Framework

6. Continuous Renal Replacement Therapy Market Segmentation

7. Continuous Renal Replacement Therapy Market Regional And Country Analysis

8. Asia-Pacific Continuous Renal Replacement Therapy Market

9. China Continuous Renal Replacement Therapy Market

10. India Continuous Renal Replacement Therapy Market

11. Japan Continuous Renal Replacement Therapy Market

12. Australia Continuous Renal Replacement Therapy Market

13. Indonesia Continuous Renal Replacement Therapy Market

14. South Korea Continuous Renal Replacement Therapy Market

15. Western Europe Continuous Renal Replacement Therapy Market

16. UK Continuous Renal Replacement Therapy Market

17. Germany Continuous Renal Replacement Therapy Market

18. France Continuous Renal Replacement Therapy Market

19. Italy Continuous Renal Replacement Therapy Market

20. Spain Continuous Renal Replacement Therapy Market

21. Eastern Europe Continuous Renal Replacement Therapy Market

22. Russia Continuous Renal Replacement Therapy Market

23. North America Continuous Renal Replacement Therapy Market

24. USA Continuous Renal Replacement Therapy Market

25. Canada Continuous Renal Replacement Therapy Market

26. South America Continuous Renal Replacement Therapy Market

27. Brazil Continuous Renal Replacement Therapy Market

28. Middle East Continuous Renal Replacement Therapy Market

29. Africa Continuous Renal Replacement Therapy Market

30. Continuous Renal Replacement Therapy Market Competitive Landscape And Company Profiles

31. Continuous Renal Replacement Therapy Market Other Major And Innovative Companies

32. Global Continuous Renal Replacement Therapy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Continuous Renal Replacement Therapy Market

34. Recent Developments In The Continuous Renal Replacement Therapy Market

35. Continuous Renal Replacement Therapy Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기